openPR Logo
Press release

Breast Biopsy Devices Market Reaches USD 3.77 Billion by 2033, Driven by Rising Demand for Minimally Invasive Diagnostics

08-06-2026 08:28 AM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Breast Biopsy Devices Market Size

Breast Biopsy Devices Market Size

According to data intelligence, the breast biopsy devices market size was valued at USD 2.25 billion in 2024 and is projected to reach USD 3.77 billion by 2033, expanding at a CAGR of 6.1% during the forecast period from 2025 to 2033. The increasing incidence of breast cancer, growing adoption of image-guided biopsy procedures, and continuous technological advancements in diagnostic devices are supporting steady market expansion.

The breast biopsy devices industry is witnessing a transition toward minimally invasive procedures, with vacuum-assisted and core needle biopsy technologies becoming standard clinical practice. Integration of MRI, ultrasound, and digital imaging guidance improves diagnostic precision while enhancing patient comfort. Hospitals and diagnostic centers are also investing in advanced biopsy platforms that streamline workflows, reduce procedure times, and improve tissue sampling accuracy, and shaping long-term innovation across the sector.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for Quick Response): https://www.datamintelligence.com/download-sample/breast-biopsy-devices-market?akash

Recent Developments
· Mammotome (2026): Received U.S. FDA clearance for the PrimaTM MR Dual Vacuum-Assisted Breast Biopsy System and HydroMARKTM Plus MR Breast Biopsy Site Marker, expanding MRI-guided biopsy capabilities.

· Mammotome (2026): Commercially launched the PrimaTM MR Dual Vacuum-Assisted Breast Biopsy System in Europe, introducing the industry's first in-room MRI-guided vacuum-assisted biopsy solution.

· Mammotome (2026): Obtained CE Mark for the HydroMARKTM Plus Breast Biopsy Site Marker, extending access across Europe.

· Hologic (2026): Announced expanded manufacturing efforts and targeted return of Brevera® 9G biopsy needles following earlier field safety actions to strengthen product availability.

Market Segmentation
· By Product

o Biopsy Needles

o Biopsy Tables

o Biopsy Wires

o Guidance Systems

o Others

· By Technique Type

o Fine Needle Aspiration Biopsy

o Core Needle Biopsy

o Biopsy Markers

o MRI-Guided Core Needle Biopsy

o Surgical Biopsy

o Wire Localization

o Sentinel Node Biopsy

· By Guidance Technology

o Ultrasound-Guided

o Mammography-Guided

o Magnetic Resonance-Guided

o CT-Guided

o Others

· By End User

o Hospitals

o Diagnostic Centers

o Others

· By Region

o North America

o Europe

o Asia-Pacific

o South America

o Middle East & Africa

Competitive Landscape
The breast biopsy devices market share remains highly competitive, with established medical technology companies focusing on product innovation, image-guided biopsy systems, precision sampling technologies, and geographic expansion. Companies continue investing in minimally invasive biopsy solutions, workflow automation, and integrated imaging platforms to strengthen their competitive positioning.

Top 5 Leading Companies:

· Hologic, Inc.

· Mammotome (Danaher Corporation)

· BD (Becton, Dickinson and Company)

· Argon Medical Devices

· Cook Medical

These companies compete through continuous product development, regulatory approvals, expanded distribution networks, physician training programs, and strategic investments in advanced breast imaging and biopsy technologies.

Speak to Our Analyst and Get Customization in the Report as per Your Requirements: https://www.datamintelligence.com/customize/breast-biopsy-devices-market?akash

Regional Analysis - Europe
Europe accounted for approximately 27% of the global market in 2024. While it is neither the largest nor the fastest-growing regional market during the forecast period, Europe continues to represent a mature and technologically advanced healthcare landscape. The region benefits from well-established breast cancer screening initiatives, increasing adoption of vacuum-assisted biopsy procedures, and favorable reimbursement policies across several countries.

Healthcare providers throughout Europe are rapidly incorporating digital mammography, MRI-guided interventions, and ultrasound-guided biopsy systems into routine clinical practice. Continuous investments in diagnostic infrastructure, combined with growing awareness of early breast cancer detection, are supporting the breast biopsy devices market growth across hospitals and specialized diagnostic centers. Furthermore, ongoing regulatory approvals for innovative biopsy systems are expected to improve procedural efficiency and patient outcomes throughout the forecast period.

Conclusion
The global market is expected to maintain steady momentum as healthcare systems increasingly prioritize early and accurate breast cancer diagnosis. Technological advancements, improved imaging guidance, and the growing preference for minimally invasive procedures continue to reshape clinical practice. Despite challenges such as procedural costs and infection risks, sustained innovation, expanding screening programs, and broader access to advanced diagnostic technologies are expected to positively influence the breast biopsy devices market forecast over the coming years.

Growing research and development activities by medical device manufacturers are accelerating product innovation, with companies focusing on ergonomic device designs, enhanced tissue sampling capabilities, real-time imaging integration, and AI-enabled navigation systems. These advancements are expected to improve procedural efficiency, reduce operator dependency, and enhance diagnostic accuracy, creating new growth opportunities for market participants.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=breast-biopsy-devices-market?akash

Industry Related Reports:

Blood Clot Retrieval Device Market Size
The Global Blood Clot Retrieval Device Market was valued at USD 2.61 billion in 2025 and is projected to reach USD 9.88 billion by 2035, growing at a CAGR of 14.19% during the forecast period (2026-2035).

Get more insights: https://www.datamintelligence.com/research-report/blood-clot-retrieval-device-market?akash

Healthcare Robotics Systems Market Growth
The global Healthcare Robotics Systems Market was valued at USD 14.53 billion in 2025 and is expected to reach USD 72.11 billion by 2035, registering a CAGR of 17.39% during the forecast period (2026-2035).

Get more insights: https://www.datamintelligence.com/research-report/healthcare-robotics-systems-market?akash

Explore more Japan reports: https://www.datamintelligence.com/jp-market-research-report?akash

Contact Us:
Sai Kiran
Business Development Manager
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About Us :
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Breast Biopsy Devices Market Reaches USD 3.77 Billion by 2033, Driven by Rising Demand for Minimally Invasive Diagnostics here

News-ID: 4596700 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Nanomedicine Market Gains Strategic Relevance as Precision Delivery, Oncology Platforms and Regulated Nanocarriers Redefine Treatment Design
Nanomedicine Market Gains Strategic Relevance as Precision Delivery, Oncology Pl …
The global Nanomedicine Market, valued at US$ 258.4 Billion in 2025, is projected to reach US$ 478.3 Billion by 2033, registering a CAGR of 8.0% during the forecast period (2026-2033), according to DataM Intelligence. The market is entering a new era of growth as healthcare providers and pharmaceutical companies increasingly adopt targeted therapies designed to improve clinical outcomes while minimizing systemic side effects. Rising investments in precision medicine, continuous advancements
Thermal Imaging Market Expands Beyond Surveillance as Predictive Maintenance, Healthcare Screening and Energy Audits Drive Multisector Demand
Thermal Imaging Market Expands Beyond Surveillance as Predictive Maintenance, He …
According to global Thermal Imaging Market is projected to grow at a CAGR of 8.3% during the forecast period 2024-2031, driven by increasing adoption of infrared imaging technologies across industrial inspection, predictive maintenance, defense, healthcare, energy, automotive, and security applications. The competitive landscape includes leading companies such as 3M Scott, Allied Vision, American Technologies Network (ATN) Corp., Avon Protection Systems Inc., Axis Communications, Draeger Safety, BAE Systems Imaging Solutions, FLIR
Cryogenic Electronics Market Size to Reach USD 5.56 Billion by 2035, Driven by Quantum Computing Advancements - DataM Intelligence
Cryogenic Electronics Market Size to Reach USD 5.56 Billion by 2035, Driven by Q …
According to Data Intelligence, the cryogenic electronics market size reached USD 1.35 billion in 2025 and is projected to reach USD 5.56 billion by 2035, expanding at a CAGR of 15.2% during the forecast period 2026-2035. The increasing commercialization of quantum technologies, rising investments in superconducting systems, and continuous innovation in ultra-low-temperature electronic components are creating strong opportunities across research laboratories, healthcare, aerospace, and high-performance computing applications. The cryogenic electronics market
GLP 1 Companion Nutrition Market Size to Reach US 18.92 billion by 2035 Driven by Rising Demand for Clinical Nutrition Support - DataM Intelligence
GLP 1 Companion Nutrition Market Size to Reach US 18.92 billion by 2035 Driven b …
According to DataM Intelligence, the global GLP 1 companion nutrition market size was valued at US 5.26 billion in 2025 and is projected to reach US 18.92 billion by 2035, expanding at a CAGR of 13.7 percent during the forecast period from 2026 to 2035. The strong outlook reflects increasing demand for specialized nutritional support among individuals using GLP 1 therapies for obesity and type 2 diabetes. The report highlights

All 5 Releases


More Releases for Biopsy

Liquid Biopsy Market - Unlocking Insights in Liquid: Transforming the Biopsy Lan …
Newark, New Castle, USA: The "Liquid Biopsy Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Liquid Biopsy Market: https://www.growthplusreports.com/report/liquid-biopsy-market/8430 This latest report researches the industry structure, sales, revenue,
Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to …
Download Free PDF Sample Papers Now at Biopsy Devices Market https://www.reportsnreports.com/contacts/requestsample.aspx?name=1159148 . Biopsy devices market report analyzes various types of biopsy devices in market and their adoption patterns. It aims at estimating market size and future growth potential of biopsy devices market for different segments such as product, guidance technique, application, end user, and region. Global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East
Biopsy Device Market to Increase to US$ 2,621 Mn by 2026 | Guidance System (Ster …
Key players focussing on strategic M&A for amplified market shares Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and
Breast Biopsy Market Report 2018: Segmentation by Product (Vacuum Assisted Biops …
Global Breast Biopsy market research report provides company profile for Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume,
Biopsy Devices Market Report 2018: Segmentation by Product (Core Needle Biopsy, …
Global Biopsy Devices market research report provides company profile for C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Bone Biopsy Market 2018 | Needle Biopsy | Open Biopsy | Bone Cancer | Bone Infec …
The Global Bone Biopsy Market is growing continuously and expected to grow at a CAGR of 5.7% from 2017 to 2023. Bone biopsy is performed to diagnose various bone disorders such as bone cancer, bone infection, osteoporosis and chronic kidney disease. Nowadays, biopsy procedure has received great importance in oncology as one of the promising methods in cancer diagnostics. The demand for needle biopsy is found to be increasing from